The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ISHARES TR | RUS 1000 VAL ETF | 464287598 | 165,255 | 1,089,714 | SH | SOLE | 0 | 0 | 1,089,714 | |||
PLIANT THERAPEUTICS INC | COM | 729139105 | 603 | 31,172 | SH | SOLE | 0 | 0 | 31,172 | |||
OPORTUN FINL CORP | COM | 68376D104 | 223 | 40,551 | SH | SOLE | 0 | 0 | 40,551 |